A compound having the general structure shown in Formula (I) or pharmaceuticallyacceptable salts and/or solvates thereof are useful in treating diseases orconditions mediated by NK receptors, for example various physiologicaldisorders, symptoms or diseases, including emesis, depression, anxiety andcough.